Emily Pimblett Eliem Therapeutics, Inc. (ELYM) insider trading activity
Emily Pimblett is CHIEF ACCOUNTING OFFICER of Eliem Therapeutics, Inc.. Currently has a direct ownership of 3,755 shares of ELYM, which is worth approximately $31,767. The most recent transaction as insider was on Jun 20, 2024, when has been sold 1,245 shares (Common Stock) at a price of $7.21 per share, resulting in proceeds of $8,976. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.76K
n/a
3M change
n/a
12M change
Total Value Held
$31,767
EP
Emily Pimblett
CHIEF ACCOUNTING OFFICER
Wilmington, DE